2025 Binaytara Global Oncology Summit conference hero image

2025 Binaytara Global Oncology Summit

Accreditation: 6.00 AMA PRA Category 1 Credit™ | 6.00 Nursing Contact Hours | 6.00 ABIM MOC II | 6.00 ACPE Pharmacy

Venue: Grand Hyatt Seattle, 721 Pine Street, Seattle, WA, United States

Start Date:
Registration Closed

Official conference page for 2025 Binaytara Global Oncology Summit.

About 2025 Binaytara Global Oncology Summit

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Hemant Khandelia
28+

Faculty and committee

Conference program and agenda

Our Agenda

Saturday, November 1st, 2025

All timings are in Pacific Time (PDT, GMT-07:00) time.

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits
08:00 AM - 08:15 AMWelcome & Opening Remarks
08:15 AM - 09:00 AMSession 1: Binaytara's Efforts

08:15 AM - 08:25 AM

Current Update of Binaytara's Mission Matt Lambert, n/a

08:25 AM - 08:35 AM

Abstract: OncoBlast: Bridging Global Cancer Education Gaps with Gamified Learning Suyog Kadel, MSc

08:35 AM - 09:00 AM

Panel Discussion Jin Mou, MD, PhD, MPH; David Aboulafia, MD; Matt Lambert, n/a; Maeve Doolin, MD PhD

09:00 AM - 10:00 AMSession 2: Changing Politics & The Effects on Global Health

Session Chair: Pat Garcia-Gonzalez

09:00 AM - 09:15 AM

Keynote Lecture Pat Garcia-Gonzalez

09:15 AM - 09:25 AM

Abstract: Global Oncology Partnership to Improve Cancer Care in Nigeria: From Concept to Memorandum of Understanding in an LMIC Setting Daniel Ezekwudo, MD, PhD

09:25 AM - 10:00 AM

Panel Discussion Benjamin O. Anderson, MD, FACS; Edus Houston Warren, MD, PhD

10:00 AM - 10:30 AMBreak & Exhibits
10:30 AM - 12:00 PMSession 3: New Treatment Relevant to Global Health

Session Chair: Mazyar Shadman, MD

10:30 AM - 10:45 AM

Keynote: Using Immune Checkpoint Inhibitors to Reduce Global Cancer Mortality Shailender Bhatia, MD

10:45 AM - 11:00 AM

New Agents in CLL Mazyar Shadman, MD

11:00 AM - 11:15 AM

New Agents in GI Tumors William P Harris, MD

11:15 AM - 11:25 AM

Abstract: Socioeconomic characteristics and incidence of cytokine response syndrome (CRS), infections, cardiac and neurological toxicity of patients treated with chimeric antigen receptor (CAR) T cell therapy Himil Mahadevia, MD

11:25 AM - 12:00 PM

Panel Discussion Vinod Pullarkat, MD

12:00 PM - 01:00 PMLunch & Exhibits
01:00 PM - 02:15 PMSession 4: Innovations

Session Chair: Cecilia CS Yeung, MD

01:00 PM - 01:15 PM

Keynote: Innovations in Molecular Diagnostics Cecilia CS Yeung, MD

01:15 PM - 01:30 PM

Molecular Diagnostics in Breast Cancer Jane Brock, MD

01:30 PM - 01:45 PM

Dried Blood Testing in CML Vivian G Oehler, MD

01:45 PM - 01:55 PM

Abstract: Edge Computing in Radiological Imaging: A Meta-Analysis of Accessibility for Cancer Detection in Low-Resource Settings Divyanshu Kumar

01:55 PM - 02:15 PM

Panel Discussion Ayokunle Olanrewaju, PhD; Jane E. Brock, MD, PhD; Vivian G Oehler, MD; Paul Lampe, PhD

02:15 PM - 03:15 PMSession 5: Public / Private Partnerships

Session Chair: Curt D. Malloy, JD, MPH

02:15 PM - 02:35 PM

Keynote: Primer on Public & Private Partnerships Curt D. Malloy, JD, MPH

02:35 PM - 02:50 PM

Unmet Need & Global Opportunity Cathyryne Manner, PhD

02:50 PM - 03:05 PM

Science Update and Target Product Profile of Breast Cancer Vaccine Peter Berglund, PhD

03:05 PM - 03:15 PM

Panel Discussion Adedamola Dada, MD

03:15 PM - 04:15 PMSession 6: Problems & Solutions on the Ground

Session Chair: Edus Houston Warren, MD, PhD

03:15 PM - 04:15 PM

Panel Discussion Manoj Agarwal, MD; Fengting Yan, MD

04:15 PM - 04:20 PMFinal Remarks & Adjourn

Venue and map

Accreditations and continuing education

Accreditation

Registration and pricing